BSEBoard Meeting11 Aug 2026 · 11 Aug 2026, 05:30 pm

Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve un-audited financial ....

Star Source Multi Trade Ltd · 506365

✦ AI SummaryResults

Star Source Multi Trade Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve un-audited financial results for the quarter ended on June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Star Source Multi Trade Ltd - 506365 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended On June 30, 2026.

Attachments (1)

📄

bce53d5d-1bcf-4ede-b499-e9ccb75f891e.pdf

pdf

Download →
View document text
STARSOURCE MULTITRADE LIMITED (Formerly known as Chemo Pharma Laboratories Limited) (CIN: L46900MH1942PLC003556) Date: August 11, 2026 Bombay Stock Exchange Limited Department of Corporate Services, 25th Floor, P. J. Towers, Dalal Street, Mumbai-400001 Script Id: 506365 ISIN: INE320M01019 Subject: Intimation of Board Meeting under Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, August 14, 2026 at the Registered Office of the Company, inter alia, to transact the following business: 1. To consider and approve the Un-Audited Financial Results for the First Quarter ended June 30, 2026 along with the Limited Review Report thereon. 2. Any other matter as Board may deem fit. Further, in continuation to our intimation and as per the SEBI (Prohibition of Insider Trading) Regulations 2015, as amended and the Company’s Code of Conduct for Prevention of Insider Trading (the “Code”), the trading window for dealing in shares of the Company by all designated persons is closed from July 01, 2026 and the same will continue remain closed and shall re- open on the expiry of 48 hours after announcement of Un-Audited Financial Results for the Quarter ended June 30, 2026. The same may please be taken on record. Thanking You. Yours Faithfully, FOR Starsource Multitrade Limited (Formerly known as Chemo Pharma Laboratories Limited) RUCHIT MEHTA Managing Director & Chief Executive Officer DIN: 08810586 Registered Office: 5 - Kumud Apartment CHS Ltd, Karnik Road, Chikan Ghar, Kalyan,– 421301, India Corporate Headquarter: 1016, North Plaza, Near D Mart, Motera, Ahmedabad– 380005, India Ph: +91-22-22078381 / 82 | Fax: +91-22-22074294 Email: chemopharmalaboratorieslimited@gmail.com | www.starsourcemultitrade.com